183 related articles for article (PubMed ID: 15804151)
1. Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery.
Li S; Ji H; Lin J; Lenehan E; Ji B; Liu J; Liu J; Long C; Crane TA
J Extra Corpor Technol; 2005 Mar; 37(1):9-14. PubMed ID: 15804151
[TBL] [Abstract][Full Text] [Related]
2. Preoperative plateletpheresis does not reduce blood loss during cardiac surgery.
Boey SK; Ong BC; Dhara SS
Can J Anaesth; 1993 Sep; 40(9):844-50. PubMed ID: 8104730
[TBL] [Abstract][Full Text] [Related]
3. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
[TBL] [Abstract][Full Text] [Related]
6. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
Lindvall G; Sartipy U; van der Linden J
Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
[TBL] [Abstract][Full Text] [Related]
8. Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation.
Al-Rashidi F; Bhat M; Pierre L; Koul B
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):618-22. PubMed ID: 17670731
[TBL] [Abstract][Full Text] [Related]
9. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
10. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
[TBL] [Abstract][Full Text] [Related]
12. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
[TBL] [Abstract][Full Text] [Related]
13. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
Mohr R; Goor DA; Lusky A; Lavee J
Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
[TBL] [Abstract][Full Text] [Related]
15. Plateletpheresis before redo CABG diminishes excessive blood transfusion.
Christenson JT; Reuse J; Badel P; Simonet F; Schmuziger M
Ann Thorac Surg; 1996 Nov; 62(5):1373-8; discussion 1378-9. PubMed ID: 8893571
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin to decrease bleeding and intraoperative blood transfusion requirements during descending thoracic and thoracoabdominal aortic aneurysmectomy using cardiopulmonary bypass.
Godet G; Bertrand M; Samama CM; Barré E; Fléron MH; Baron JF; Coriat P; Kieffer E; Viars P
Ann Vasc Surg; 1994 Sep; 8(5):452-6. PubMed ID: 7529038
[TBL] [Abstract][Full Text] [Related]
17. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
18. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
[TBL] [Abstract][Full Text] [Related]
19. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
